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ABSTRACT 
Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) that causes chronic 
inflammation and ulcers affecting the innermost layer of the colon. Almost 1 million people 
suffer from UC in the United States. UC patients have an increased risk of colitis associated 
cancer (CAC). It is driven by continuous exposure to inflammation and progresses through 
“dysplasia-carcinoma axis”. Notch1 signaling is a conserved intracellular signaling pathway. It 
regulates cell fate, proliferation, differentiation, and death. However, Notch1 acts as a mediator 
or suppressor depending on the cellular context and disease stage. Aim of this study is to 
understand the mechanistic role of Notch1 in acute colitis and CAC. We used WT mice (control 
group) and crossed them with villin-cre mice to generate NCre, which cannot express Notch1 in 
colon epithelium. Acute colitis was induced with dextran sodium sulfate (DSS) for five days and 
in recovery period, mice were given water after the completion of DSS cycle. CAC was induced 
by intraperitoneal injection of azoxymethane and two cycles of DSS. Enteroids were isolated 
from six weeks old NCre and WT mice to study proliferation and differentiation. Inhibition of 
Notch1 compromised epithelial crypt architecture, led to higher number of goblet cells, and 
compromised intestinal barrier function at the basal level. Notch1 mediated inflammation in 
DSS- induced acute colitis by increasing inflammatory cytokine levels and activating NF-kB 
pathway. In the acute colitis model following a recovery period, Notch1 promoted wound 
healing. In CAC, NCre mice showed higher susceptibility to inflammation as indicated by 
histology, higher number of polyps, and defective barrier function compared to WT mice. 
Western blot data showed increased p53 and cleaved caspase-3 expressions while decreased 
expressions of γ-H2AX and MLH1. Notch1 mediates acute colitis by cross-talking with NF-kB 
pathway and promoting abnormal proliferation. However, during the recovery period after acute 
colitis, Notch1 promotes wound healing. Inhibition of Notch1exarcebates CAC condition due to 
lower levels of non-mutated p53 expression. Therefore, this study suggests that Notch1 inhibitors 
might be a better option as therapeutics only for acute colitis patients and induction of Nocth1 
signaling as a therapy, can protect against chronic colitis/CAC. 
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1 GENERAL BACKGROUND  
1.1 Inflammatory bowel disease 
Inflammatory bowel disease (IBD) is an incurable chronic inflammatory condition that 
affects the gastrointestinal (GI) tract [1, 2]. Around 3.1 million adults, in the United States, have 
being diagnosed with IBD [3]. This disease affects the quality of life, bringing substantial 
morbidity and complications that require hospitalizations and surgeries  [4] . The exact cause of 
this disease is yet not known but studies appoint it to be hereditary, to environmental factors, or 
to abnormal immune responses [5].  There are two major forms of IBD: Crohn’s disease (CD) 
and Ulcerative colitis (UC). Both share similar symptoms; however, they also have remarkable 
differences in the location of inflammation and progression in the GI tract. CD commonly affects 
the small intestine, proximal colon, and all the layers of the GI tract, while UC is characterized 
by continuous inflammation of the rectal and colonic mucosal layers of the GI tract. 
1.1.1 Ulcerative colitis 
UC leads to epithelial barrier dysfunction affecting major components of the GI tract 
such as epithelial cells, goblet cells, immune cells, and commensal flora [1, 6]. In UC, due to 
inflammation, epithelial cell integrity is compromised resulting in the continuous stimulation of 
the mucosal immune system and the dysregulation of colonic permeability [7]. Permeability 
dysregulation allows the influx of pathogenic foreign substances and the efflux of immune cells 
leading to the development of chronic inflammation and then ulceration [8]. Due to this 
dysfunction, inflammatory responses inhibit the repair of tissue damage to fix mucosal 
homeostasis. Inflammation in short term can be a beneficial response; however, prolong 
inflammation can contribute to create a potential tumorigenic microenvironment [9].  
2 
1.2 Colitis associated cancer 
 
 
 
 
 
Patients with chronically active UC have a 15- 40% risk of developing colon associated 
cancer (CAC) due to the long duration of the inflammation in the colon [4]. CAC is a subtype of 
colorectal cancer, but several features make CAC specific and distinct from sporadic colorectal 
cancer (CRC) [10, 11]. While CRC develops from adenoma to carcinoma, CAC develops from 
dysplastic tissues among chronically active UC patients (Figure 1) [12]. CAC also presents a 
higher number of polyps in the distal colon region compared to CRC [8]. In CAC, chronic 
inflammation nurtures the tumor microenvironment and initiates carcinogenesis. Indeed, chronic 
inflammation favors to the secretion of proinflammatory cytokines, such as IL-1β, TNF-α, and 
IL-6, which promote the accumulation of reactive oxygen species (ROS) and maintains a pro-
inflammatory environment favorable for oncogene activation and tumor suppressor gene 
mutations, activation of abnormal proliferation and differentiated anti-apoptotic pathways [10]. 
This disrupts the colonic epithelial homeostasis exposing the epithelial mucosa and adjacent cells 
Figure 1. CAC progression (above) vs. CRC progression (below).  
CAC progresses from dysplasia to adenocarcinoma, while CRC develops from adenoma 
to carcinoma. 
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to inflammatory luminal content. This is followed by the alteration of immune responses, DNA 
damage, and mutations in DNA damage response genes [13-15]. 
1.3 Notch signaling 
1.3.1 Notch family receptors 
The Notch gene was first identified in Drosophila melanogaster and encodes a 300kD 
type I transmembrane receptor [16, 17]. Notch signaling is a conserved mechanism that controls 
a variety of cell fates and developmental pathways in different organisms that range from sea 
urchins to humans [18, 19]. In mammals, Notch proteins comprise a family of four receptors 
(Notch1-4) whose activity is controlled by Delta-like 1 (Dll1), Dll3, Dll4 and Jagged 1 (Jag1) 
and Jag2 family ligands [20-22]. The mutation of the Notch receptor has resulted in 
developmental abnormalities and in human pathologies as well [23, 24]. 
1.3.2 Notch1 structure and activation 
 
 
 
 
 
 
 
 
 
Notch1 contains four regions: a) extracellular epidermal growth factor (EGF)-like 
domains b) the negative regulatory region composed by three cysteine-Lin repeats and the 
Figure 2. Notch1 protein domain structure. 
Abbreviations used are: ANK, ankyrin repeats; c, cleavage site at site 1,2 and 3; 
EGF, epidermal growth factor; HD, heterodimerization domain; LNR, Lin-Notch 
repeats; NRR, negative regulatory region; PEST, proline (P), glutamic acid (E), 
serine (S) and threonine (T) degradation domain; RAM, Rbp-associated molecule 
domain; SP, signal peptide; TAD, transactivation domain; TM, transmembrane 
domain. Adapted from (Jan Mašek and Andersson, 2017). 
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heterodimerization domain, c) the transmembrane domain, d) Notch intracellular domain (NICD) 
which contains a RBPjκ association module (RAM) domain, seven ankyrin repeats, a 
transcription activation domain, and a transactivation domain containing degrons which regulate 
the stability of NICD (Figure 2). 
Successful interaction of Notch1 receptor with the ligand, present in the neighboring 
cells, is mediated by 11-12 EGF repeats (trans interaction), while inhibitory interaction with the 
ligand, expressed in the same cell, is mediated by 24-29 EGF repeats (cis interaction) [25]. The 
Notch pathway can be activated canonically and non-canonically [26, 27]. The canonical 
signaling is well known to have a role during the early steps of organ development and the 
maintenance of cells of the organ [28, 29]. In the colon, Notch1 is required for the maintenance 
and differentiation of intestinal stem cells in the colon and maintains the balance between 
absorptive (epithelial cells) and secretory lineages (goblet, Paneth, tuft, and enteroendocrine 
cells) [30, 31]. Canonical activation of Notch1 results of three cleavages, two extracellular and 
one intracellular (Figure 3). The canonically activation starts when any Delta or Jag family 
ligand binds to extracellular Notch receptors located on the cell surface. This binding will trigger 
a first extracellular cleavage, mediated by furin-like proteases such as convertase, in the trans-
Golgi network. The second extracellular cleavage is mediated by serine proteases or 
metalloproteases. Lastly, a third intracellular cleavage is mediated by intracellular γ-secretase 
generating the active Notch1 intracellular domain (NICD). NICD translocates to the nucleus 
where it forms a complex with transcription regulatory factors (CSL/RBP-J). This complex then 
allows the displacement of co-repressors [32] and the recruitment of co-activators [33] that 
activate the transcription of target genes such as c-Myc, p53, ARF, and Hes [20, 34, 35].  
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Very recently, the non-canonically activation of Notch1 has also been identified and is 
found to be involved with physiological and pathological cellular processes [36], such as cancer 
[37] and activation of the immune system. This differs from the regular cellular processes driven 
by the canonical Notch1 pathway. The non-canonical activation is RBP-Jk independent and 
plays an important role in the oncogenesis process in certain cell types. Some of the mechanisms 
that can activate Notch1 pathway crosstalk with any pathways such as β-catenin/Wnt signaling, 
MAPK, mTOR, etc [26]. 
 
 
Figure 3. Notch1 signaling canonical activation. 
 
 
 
1.3.3 Notch1 expression in the colon 
Notch1 is highly expressed at the basal crypt of the colon and in the colon lamina propria 
cells [38, 39]. Notch1 signaling also orchestrates different biological functions such as cell 
Interaction between Notch1 receptor and Notch ligands (Jagged/Delta) triggers two 
consecutive proteolytic cleavages by a metalloprotease and the γ-secretase complex. This 
generates NICD, which enters the nucleus and displaces corepressors (SMRT and CtBP1) and 
recruits the coactivator MAML1 and the acetyltransferase p300, resulting in the transcription 
of genes bound to the NICD-RBP-J complex, such as Hes. Adapted schematics (Lobry et al., 
2014; Ranganathan et al., 2011) 
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differentiation, proliferation, apoptosis, cell-fate, etc. controlling the organ morphogenesis as well 
as tissue homeostasis [20, 21] [40, 41]. Notch1 can activate Hes transcription factor implicated in 
the maintenance of progenitor and stem cells; thus, promoting epithelial cell differentiation in the 
colon [39].  Because Notch1 plays a critical role in these essential processes in the colon tissue, 
the dysregulation of Notch1 can contribute to multiple abnormalities that range from 
developmental disorders [42] [43]  to inflammation and then cancer [44]. 
 
2 THE ROLE OF NOTCH1 IN ACUTE COLITIS 
2.1 Introduction 
UC is characterized by continuous inflammation of the rectal and colonic mucosal layers 
which extends proximally [4]. UC leads to epithelial cell barrier dysfunction affecting GI tract 
major components such as epithelial cells, goblet cells, immune cells, and commensal flora [1, 
6]. Because of this alteration, inflammatory responses arise to help repair colonic injury and fix 
tissue homeostasis. 
Intestinal homeostatic renewal of the damaged epithelial monolayer is mediated by a pool 
of intestinal stem cells (ISCs) called crypt base columnar cells (CBCs), which are constantly 
generating new progenitors. CBCs are found intercalated with Paneth like cells at the crypt of the 
colon highly expressing the G protein coupled receptor 5 gene (Lgr5) [45]. Notch1 receptor is 
expressed in CBCs promoting active Notch1 signaling in these cells to allow their differentiation 
into epithelial cells [46] while also serving as a marker for Lgr5 positive cells. 
In UC, goblet cells are decreased or depleted [47-49]. Goblet cells main role is the 
secretion of Mucin 2 (MUC2), a component of colonic mucus, which protects the mucus layer, 
against luminal stimulants and pathogens. Differentiation of ISCs into goblet cells is facilitated 
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by Math1, an antagonistic of Notch1 transcription factor-Hes 1, which promotes the 
differentiation of secretory cells into goblet, Paneth, and enteroendocrine cells [50, 51].  
The colonic epithelium barrier also acts as a line of defense against foreign antigens such 
as toxins and microorganisms [8, 52]. Colonic epithelial integrity is defined by apical junctions 
comprising tight junctions (TJs), adherent junctions (AJs), and adjacent colonic epithelial cells 
[53, 54]. TJs are apical protein complexes formed by transmembrane proteins, claudins, occludin 
and tricellulin. All three are connected to the actin cytoskeleton via zona occludens (ZO). In UC, 
epithelial integrity is compromised allowing the influx of pathogenic foreign substances which 
are recognized by toll like receptors (TLRs) from macrophages and dendritic cells leading to the 
activation of pro-inflammatory cytokines such as TNF-α, interlukin-6 (IL-6),  and IL-1β. Notch1 
receptor activation has been confirmed in studies done by the induction of synthetic TLRs using 
bacterial pathogens suggesting that TLRs can indirectly promote the activation of Notch1 [55]. 
The immediate repair response to an injured intestinal epithelial layer is the restitution 
process of epithelial cells. During this process, local epithelial cells redistribute around the 
wound to reseal and restore the continuity of this layer but most importantly to preserve colonic 
homeostasis. This first step does not require cell proliferation [56], but it does require other 
factors such as cytokines [57, 58], cell adhesion molecules [59], and trefoil factors [56]. Cell 
proliferation is required after restitution to replenish the decreased pool of epithelial cells. 
Epithelial cell proliferation is induced by the secretion of growth factors [60] from local 
epithelial cells and mesenchymal cells close to the injury. Hes-1, a downstream target of Notch1 
signaling, drives progenitor cells to differentiate into absorptive epithelial cells. 
The pathogenesis of UC tells us that there is loss of the mucosal immune system and 
epithelial cell integrity [61], linking the regenerative process disturbance directly with Notch1 
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functions in the colon. Therefore, understanding the role of Notch1 in UC can assist in 
understating the mechanism by which Notch1 mediates inflammation in UC. 
2.2 Materials and Methods 
2.2.1 Animal models 
All animal procedures were performed in accordance with the Guide for the Care of Use 
of Laboratory Animals as described previously [58]. Eight-weeks old, both female and male, 
Villincre/+; Notchflox/flox (NCre) and wild-type (WT) C57/B6 background were used in these 
studies. 
To investigate the role of Notch1 in acute colitis and CAC, epithelial cell-specific 
deletion of Notch1 was done using the Cre/Lox system. Mice harboring a floxed promoter region 
of the Notch1 gene (Notch1loxP/+) were purchased from The Jackson laboratory. The Notch1loxP/+ 
were bred to generate NotchloxP/loxP and were monitored for healthy development and fertility 
until maturity. Notch1loxP/loxP were bred with Villin-cre in which ‘cre’, under the control of the 
villin promoter, is specifically expressed in epithelial cells to generate Villincre/+; Notchflox/flox 
(NCre) mice. The Notch1 suppression among NCre mice was identified by using PCR 
genotyping using Notch forward primer (5′-GCAGTTGTGCTCCTGAAGAA-3′) and reverse 
primer (5′-CGGGCGGCCAGAAAC-3′). 
2.2.2 Acute colitis (AC) induction and recovery phase 
Eight weeks-old, both female and male, NCre and WT mice were induced with acute 
colitis by one cycle of 2% Dextran sodium sulfate (DSS) (MP Biomedicals, Solon, OH) by oral 
administration through their drinking water for 5 days (Figure 4). To study the role of Notch1 in 
recovery period after acute colitis, another set of mice were treated with one cycle of 2% DSS for 
five days and then they were allowed to recover for 7 days. Mice was euthanized on day 12 
9 
(Figure 4). Control group mice, NCre and WT, were given regular water for the same amount of 
days. Body weight and stool consistency for all the mice were recorded during both, DSS and 
recovery phase.   
 
2.2.3 Cell culture and wound healing assay 
HCT116 cells, colon human carcinoma cells, were cultured with DMEM medium 
(GIBCO, Invitrogen) supplemented with 10% FBS (Atlanta Biologicals), and 100 units/ml 
penicillin, and 100 mg/ml streptomycin (GIBCO) at 37ᵒC in 5% CO2. 
Cells (5 x 105) were seeded in 6 well plates and incubated for 24 hrs. When cells were 
70-90% confluent, cells were then transfected with or without NICD DNA construct (a kind gift 
from Dr. R. Kopan, University of St. Louis). 24 h after transfection, monolayer was wounded by 
scratching method with a sterile pipette tip and images were taken at 0, 24, and 48 hrs by using 
Keyence BZ-X700 microscope. Transfection efficiency was done by collecting cell lysates at the 
mentioned time points and were probed with anti-NICD (Cell Signaling). 
2.2.4 Protein extraction and Western Blot (WB) analysis 
Colon mucosal stripping was obtained from NCre and WT mice with and without acute 
colitis. Antibodies used were anti-NICD (Cell Signaling), anti-COX-2 (Cayman chemical), anti-
Figure 4. DSS- induced acute colitis model and DSS-induce colitis recovery model. 
Abbreviations used are: D-Day and DSS-Dextran sodium sulfate 
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NFkB (Cell Signaling), anti-iNOS (Millipore), and anti-Cyclin D1 (Santa Cruz Biotechnology). 
Goat anti-mouse secondary antibody (Bio-Rad) or goat anti-rabbit secondary antibody (Abcam) 
were used. β-tubulin (Sigma-Aldrich) was used as loading control. 
2.2.5 Mouse colonoscopy 
NCre and WT mice with and without acute colitis were subjected to colonoscopy to 
assess the mucosal layer thickness due to inflammation and dysplastic lesions. This was 
performed using the colonoscope (Xenon Nova 47S, STORZ). 
2.2.6 Hematoxylin and Eosin (H&E) staining and histological score evaluation 
Formalin fixed and paraffin embedded colon Swiss rolls from NCre and WT mice with 
and without acute colitis were used. Histological scores were evaluated based on inflammation-
infiltration of white blood cells, crypt damage, and foci of ulceration in the entire colon [62, 63]. 
Images were taken using Keyence BZ-X700 microscope at X20 and X40 magnification. 
2.2.7 Alcian Blue-Periodic Acid Schiff (AB-PAS) staining 
Formalin fixed and paraffin embedded colon Swiss rolls from NCre and WT mice with 
and without acute colitis were used. Sections were hydrated and incubated with acetic acid for 3 
min. Next, sections were stained with 3% Alcian blue (Sigma-Aldrich). After washing, sections 
were incubated with 0.5% periodic acid and then with Schiff reagent (Sigma-Aldrich) at room 
temperature. Sections were then hydrated with alcohol, cleared with xylene, and sealed. Images 
were taken using Keyence BZ-X700 microscope at X20 magnification. 
2.2.8 In-vivo permeability assay 
Eight weeks-old age, both female and male, NCre and WT mice were gavaged with 
permeability tracer (60 mg/100g body weight of FITC-labeled dextran) (Sigma-Aldrich). Serum 
was collected retro-orbitally 4 h after gavage and fluorescence intensity of each sample was 
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measured at λex=492 nm; λem= 525 nm by using Synergy 2; BioTek. FITC-dextran 
concentrations were determined from standard curves generated by serial dilutions of FITC-
dextran and permeability was calculated by linear regression of sample fluorescence [64, 65]. 
2.2.9 Myeloperoxidase (MPO) assay  
NCre and WT with and without AC colon tissue samples were homogenized in cold 
potassium phosphate buffer (50 mmol/l K2HPO4 and 50 mmol/l KH2PO4, pH 6.0) containing 
0.5% hexadecyltrimethylammonium bromide (Sigma-Aldrich). The homogenates were 
sonicated, freeze-thawed three times, and centrifuged. MPO activity in the samples was 
determined and compared to MPO standard after measuring the absorbance at 450nm [64].  
2.2.10 Colonoid extraction 
Crypts were isolated from six weeks NCre and WT mice. Crypts were grown to colonoids 
[66] on Matrigel (Corning, New York, NY) in a 24 well plate. Then, the growth of colonoids on 
the plates, were observed every day and images were taken at X10 and X20 magnification with 
ZEISS Primovert AxioCam MRm microscope for days 2, 4, 7, and 9. 
2.2.11 RNA extraction and QPCR analysis 
Total RNA was extracted from colonic tissues using the RNeasy mini Kit (Qiagen) 
according to the manufacturer’s instructions. Then, complementary DNA was generated from the 
earlier-described total RNA isolated using the Maxima first-strand complementary DNA 
synthesis kit (ThermoFisher Scientific). mRNA expression was quantified by quantitative real-
time reverse-transcription polymerase chain reaction using Maxima SYBR green quantitative 
polymerase chain reaction Master Mix (ThermoFisher Scientific). The following sense and 
antisense primers (Table 1) were used: IL-6, IL-1β, TNF-α, IFN-γ, IL-17, and 16SrRNA. Real-
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time PCR data is presented using the DDCT method and using 36B4 gene levels as the internal 
standard. 
 
 
Table 1. Sequences of the QPCR primers used in the study. 
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2.2.12 Immunofluorescent staining of colon Swiss rolls and colonoids 
NCre and WT colon Swiss rolls were formalin fixed and paraffin embedded for 
immunofluorescence staining. Colon swiss rolls were deparaffinized and tissue was hydrated 
with graded concentration of ethanol. For antigen retrieval, proteinase K (Denville Scientific 
Inc.) was used for 1 hr at 37ᵒC. Slides were washed with 0.01% TPBS 3 times for 5 mins. 
Endogenous peroxidase activity block and immunostaining was performed according 
manufacture’s protocol using the Alexa Fluor™ 488 Tyramide SuperBoost™ Kit, goat anti-
rabbit IgG. Primary antibody used was anti-Lgr5 (Abcam). Colon Swiss rolls were inoculated 
with Hoechst 3342, Trihydrochloride, Trihydrate in 1X PBS for 30 mins, washed with 1X PBS, 
and finally inoculated with TRITC-phalloidin diluted with 1X PBS for 1 h [67]. Images were 
taken with Keyence BZ-X700 microscope at X40. 
NCre and WT colonoids were grown on Matrigel for 4 days in Tissuetek chambered 
slides (Thermo-Fischer) for immunofluorescence staining. Colonoids were fixed with 4% 
paraformaldehyde solution for 2h, washed with 1X PBS, and inoculated with FocusClearTM for 
2 nights [68]. Colonoids or Swiss rolls were permeabilized with 2% TritonX100 solution and 
washed with IF buffer (0.2% TritonX100, 0.05% Tween 20 in 1X PBS). Blocking buffer (2% 
TritonX100, 10% goat serum, and 0.02% sodium azide in 1XPBS) was used and then, colonoids 
were inoculated with primary antibody anti-TFF3 (Millipore Sigma), and anti-PCNA (Abcam) in 
dilution buffer (0.25% TritonX100, 1% normal serum goat, 0.02% sodium azide in 1X PBS) 
overnight. Colonoids were washed with IF buffer and inoculated later with secondary antibody 
anti-rabbit Alexa Fluor 488- green (ThermoFisher) for 2 nights. After washing, colonoids were 
inoculated with Hoechst 3342, Trihydrochloride, Trihydrate in dilution buffer for 1h, washed 
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again with IF buffer, and finally inoculated with TRITC-phalloidin in dilution buffer for 2 h. 
Images were taken with Keyence BZ-X700 microscope at X40. 
2.2.13 Blood biochemical analysis 
Blood samples (100µL) were collected retro-orbitally from, both female and male, NCre 
and WT mice. Biochemical analyses were obtained by loading the blood sample in VetScan roter 
spins and measuring the chemical parameters by the biochemical analyzer VetScan VS2, Abaxis. 
2.2.14 Statistical analysis 
All data was expressed as means ± SEM and were compared by Student’s t-test [69]. P 
values <0.05 was considered statistically significant. 
2.3 Results 
2.3.1 Characterization of NCre mice 
To study the role of Notch1 in acute versus chronic inflammation in colon, NCre mice 
was generated by crossing Notch1loxP/loxP and Villin cre mice (C57/B6 background) in which 
“cre” (under the control of the villin promoter, is expressed in colon epithelial cells). Eight 
weeks old, both female and male, NCre mice along with their wild type WT mice were used for 
these studies. The Notch1 deletion among NCre mice was identified by using PCR genotyping. 
Figure 5A-i shows the genotyping result where lanes 2-4 are homozygous NCre mice expressing 
only one band (281 bp) while lanes 6, 8, and 9 are heterozygous mice, expressing two bands, the 
mutant and the WT (281 and 231 bp, respectively). To confirm Notch1 deletion at protein level, 
protein lysates were prepared from NCre and WT mice vital organs such as colon, small 
intestine, and liver. Figure 5A ii-iii show the western blot analysis from colon and small intestine 
respectively indicating the lack of NICD (Notch1 intracellular domain- cleaved or active Notch1) 
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presence in colon (lanes 4-6) and small intestine (lanes 3-4), among NCre mice compared to WT 
mice. However, Figure 5A- iv shows presence of Notch1 signaling in the liver of NCre mice 
(lanes 4-6). 
To assess the histological changes in the colon due to the conditional deletion of Notch1, 
H&E staining was performed as described in the methods section. Figure 5B shows the H&E 
images indicating disrupted crypt architecture, increased neutrophil infiltration, and a few foci of 
ulceration among NCre mice compared to WT mice. Figure 5C is a bar graph representation of 
the histological score calculated on three parameters as described in the methods section. The bar 
graph shows that NCre mice had a significantly higher histological score (2.6 ± 0.9) compared to 
WT mice (0.7 ± 0.6). Notch1 mediates enterocyte population against goblet cells, mucus 
secretory cells, during stem cell differentiation in colon [38]. To assess the goblet cell 
hyperplasia due to the conditional deletion of Notch1 signaling, AB-PAS staining was 
performed. Figure 5D shows AB-PAS images indicating that NCre had more goblet cells as 
indicated by red arrows compared to WT mice. Figure 5E is the bar graph representation of the 
quantification of goblet cells indicating that NCre mice had a significantly increased percentage 
of goblet cells (41.49% ± 1.97) compared to WT mice (25.93% ± 4.84).  
To assess the role of Notch1 in maintaining epithelial integrity, 4kD FITC–dextran 
uptake assay was performed.  Figure 5F shows that epithelial barrier was compromised as NCre 
mice showed a higher number of FITC units (33.0 ± 7.8) compared to WT mice (11.8 ± 3.9). 
These results together indicate that inhibition of Notch1 signaling compromises epithelial cell 
integrity due to higher number of goblet cells and impaired intestinal barrier function.  
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Figure 5. Conditional deletion on Notch1 signaling in mice colon leads to the loss of epithelial 
crypt architecture, increased goblet cell population, and a defective intestinal barrier function. 
 
NCre mice were generated by using a conditional knockout method of ‘Villin-cre’ system and 
WT mice were used as a control.  (A) (A-i) Qualitative PCR of the DNA extracted from mice 
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tails with the primers designed by the supplier (Jackson Laboratories). Homozygous NCre mice 
has one mutant band at 281 bp while heterozygous mice have two bands, the mutant at 281 and 
the WT at 231 bp. Lane 1 is 100 bp ladder. Each lane shows blots that were performed loading 
(25μg/lane) using whole organ cell lysate of (A-ii) colon (A-iii) small intestine (A-iv) liver 
probed with anti-NICD. GAPDH was used as a loading control. (B) H&E staining of NCre and 
WT colon Swiss rolls (n=5 per group). H&E images were taken at X20. Magnified view of the 
squared area is shown in the right panel of the original picture at X40. (C) Bar graph presentation 
of the histological score calculated on three parameters- infiltration of neutrophils, loss of crypt 
architecture, and foci of ulceration. (D) NCre and WT colon swiss rolls (n=5 per group) were 
stained with AB-PAS. Images were taken at X20 magnification. Red arrows show goblet cell 
population. (E) Quantification of goblet cell percentage was obtained by counting goblet cells 
per epithelial cell crypt (12 crypts/mice). (F) In vivo permeability was performed by gavaging 
NCre and WT mice with 4kD FITC-dextran in PBS (60mg/100g body weight). Then, serum via 
retro-orbitally was collected after 4 hrs., and the fluorescence within the blood was measured at 
λex=492 nm; λem= 525. Each bar represents mean ± S.E., *p<0.05, ***p<0.001. 
 
2.3.2 Conditional deletion of Notch1 in colonic epithelium compromises epithelial 
cell differentiation and proliferation in the colon 
To investigate the effects of the absence of Notch1 signaling on stem cell differentiation, 
immunofluorescence staining of stem cell marker, Lgr5, was performed using colon Swiss rolls 
from NCre and WT mice. Figure 6A shows a higher expression of Lgr5, as indicated by white 
arrows, among WT compared to NCre colon crypts. To further see the effect of Notch1 silencing 
in colonic stem cell differentiation and proliferation, three dimensional colonoids isolated from 
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NCre and WT mice were used as ex vivo model. Figure 6B i-iv shows the images of crypts 
growing into colonoids monitored for days 2,4,7, and 9, respectively. Figure 6-iv shows that 
crypts isolated from NCre mice differentiated slowly as the colonoids look smaller and less 
branched compared to the colonoids from WT mice. Figure 6B-v shows a line graph representing 
the measured area of organoids per day and it indicates that NCre colonoids had significantly 
decreased area on the days 2,4,7, and 9 compared to WT colonoids. Additionally, 
immunofluorescent staining of 4 days old colonoids was performed by probing fixed NCre and 
WT colonoids with PCNA (proliferation marker) and TFF3 (goblet cell differentiation marker). 
Figure 6C-i shows PCNA staining images indicating less expression among the NCre derived 
colonoids compared to WT   derived colonoids. Figure 6C-ii shows TFF3 staining images 
indicating high expression (as a goblet cell marker) among NCre derived colonoids compared to 
WT derived colonoids. Together these data imply that Notch1 signaling plays a critical role in 
maintaining the stem cell differentiation and proliferation of epithelial cells in the colon. 
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Figure 6. Conditional deletion of Notch1 compromises colonic epithelial cell differentiation 
and proliferation. 
 
(A) NCre and WT colon Swiss rolls were probed with anti-Lgr5. FITC as green fluorescence was 
used as secondary antibody. (B) Crypts isolated from NCre and WT mice colons were grown on 
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Matrigel to form colonoids in 24 well plates. Colonoid formation was observed and images were 
captured on (B-i) day 2 and (B-ii) day 4, at X20 magnification, and (B-iii) day 7 and (B-iv) day 9 
at X10 magnification. (B-v) Organoid area was measured (6 organoids/ phenotype) by using 
ImageJ program and values are shown in X 104cm2. (C) Immunofluorescence staining of the 4 
days old NCre and WT derived colonoids, fixed in chambered slides (n=4 wells per group), were 
probed with (C-i) anti-PCNA and (C-ii) anti-TTF3. FITC as green fluorescence was used as 
secondary antibody. Images are the Z-sections at X40 magnification. DAPI was used to 
counterstain nuclei with blue fluorescence and red fluorescence is for actin-phalloidin. Each bar 
represents mean ± S.E., *p<0.05, **p<0.01. 
2.3.3 NCre mice presents increased levels of biochemical parameters 
To evaluate the alteration of biochemical parameters due to the conditional deletion of 
Notch1 signaling in vivo, VetScan VS2, a chemistry blood analyzer machine, was used. Blood 
samples (100 µL) from NCre and WT mice were collected for biochemical analysis. As shown 
on Table 1, this analysis revealed a higher number of the following functional parameters: ALB 
(3.6 ± 0.1; 3.96 ± 0.2), ALT (28.8 ± 2.3; 34.4 ± 2.5), GLU (180.8 ± 37; 287.4 ± 37.3), TP (4.52 ± 
0.2 4.8 ± 0.1), and AMY (543.8 ± 94.6; 665.2 ± 47.3) among NCre  mice compared to WT  mice, 
respectively. Together this data indicates that the lack of Notch1 expression in the colon, leads to 
increased levels of ALB and GLU indicating the inflammation in liver. 
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 Table 2. Biochemical analysis of NCre and WT mice. 
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2.3.4 Nocth1 signaling mediates inflammation in DSS- induced acute colitis 
Eight weeks old, both female and male, NCre mice and WT mice were induced with acute colitis 
by DSS as described in the methods section. Body weight of mice was monitored throughout the 
experiment and mice were euthanized at day 5. Figure 7A shows the body weight change in 
percentage indicating a significant increase in body weight among NCre mice compared to WT 
mice at day 5 of DSS-induced with colitis. Figure 7B shows colonoscopy images indicating the 
thickening of mucosa and bleeding among WT mice compared to NCre mice. To assess 
inflammation among NCre and WT mice in acute colitis, MPO assay was performed as 
described in the methods section. Figure 7C is the bar graph representation of the MPO activity 
of the colon indicating that NCre mice had significantly lower (3.63 ± 0.17) MPO activity 
compared to WT mice (7.14 ± 1.18) in acute colitis. To assess the severity of inflammation in 
NCre mice induced with colitis, H&E staining was also performed.  Figure 7D shows H&E 
images indicating crypt architecture damage, infiltration of neutrophils, and loci of ulceration 
among WT mice compared to NCre mice in acute colitis. Figure 7E shows AB-PAS images 
indicating that NCre had a decreased number of goblet cells but non- significant, as indicated by 
red arrows, compared to WT mice in acute colitis. Figure 7F is the bar graph quantification of 
goblet cells indicating there was no significant difference in goblet cell population between NCre 
mice (37.5 ± 5.3) and WT mice (38.2 ± 3.35) in acute colitis.  
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NCre and WT mice (n=5 each group) were treated with one cycle of 2% DSS for 5 days. Body 
weight was monitored every day and mice were euthanized at day 5. (A) Line graph 
representation of body weight change in percentage of NCre and WT mice with DSS- induced 
acute colitis. (B) Colonoscopy images from WT mice (top panel) and NCre mice (bottom panel) 
Figure 7. Notch1 signaling mediates inflammation DSS-acute colitis 
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with or without induced colitis. (C) Bar graph representation of MPO activity. (D) H&E staining 
of colonic Swiss rolls from NCre and WT mice in acute colitis at X20. (E) AB-PAS staining of 
colon Swiss rolls from NCre and WT mice with acute colitis. Images were taken at X20 
magnification. (F) Quantification of goblet cell was obtained by counting goblet cells per 
epithelial cell crypt (12 crypts/mice). Each bar represents mean ± S.E., *p< 0.05, **p< 0.01, 
***p< 0.001. 
2.3.5 Notch1 signaling modulates cytokines levels in acute colitis 
To assess the inflammatory environment, mRNA levels of cytokines that are known to 
mediate acute inflammatory progression to acute colitis were measured by qPCR as described in 
the methods section. Interestingly, the mRNA levels of IL-6 were significantly low among NCre 
mice (7.48 ± 1.4-fold) compared to WT mice (15.08 ± 1.80-fold) (Figure 8A). Figure 8B-E 
shows significantly increased mRNA levels of IL-1β (3.27 ± 0.53-fold), TNF-α (2.89 ± 1.10-
fold), IFN-γ (9.19 ± 2.39-fold), and IL-17 (9.58 ± 0.4.82-fold) among NCre mice compared to 
WT mice (1.10 ± 1.04, 1.37 ± 0.42, 1.50 ± 1.36; 1.62 ± 1.57- fold). These results together 
indicate that Notch1 signaling mediates DSS-induced colitis and is associated with upregulation 
of pro-inflammatory and downregulation of anti-inflammatory cytokines. 
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Figure 8. Notch1 signaling modulates inflammatory cytokines levels in acute colitis. 
 
Bar graph representation of qPCR analyses representing mRNA levels of cytokines in colonic 
mucosal stripping from NCre and WT mice with acute colitis. Relative change in mRNA levels 
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of the cytokines (A) IL-6 (B) IL-1β (C) TNF-α (D) IFN-γ and (E) IL-17 are shown. Each bar 
represents mean ± S.E., *p< 0.05, **p< 0.01. 
SDSSSSSSSSNotch1 signaling mediates NF-kβ activation in acute colitis 
To assess the mechanistic pathway by which Notch1 signaling mediates acute colitis, 
western blot (WB) analysis was performed to identify the inflammatory signaling pathways. 
Figure 9A shows no significant difference in COX-2 protein levels among both groups. Figure 
9B shows negligible levels of i-NOS protein in both groups. Figure 9C and 9D shows decreased 
protein levels of NF-kB and its downstream target, Cyclin D1, respectively among NCre mice 
(lanes 4-6) compared to WT mice (lanes 1-3). NF-kB is a pro-inflammatory signaling pathway, 
regulating the secretion of inflammatory cytokine levels [70] and Cyclin D1 regulates cell cycle 
progression [71]. Together these data indicate that Notch1 activates NF-kB inflammatory 
pathway promoting abnormal cell proliferation and thereby favoring inflammation in acute 
colitis. 
 
 
 
 
 
 
 
 
 
Figure 9. Notch1 signaling is associated with increased expression of NF-kB and Cyclin D1 in 
acute colitis. 
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WB analyses of whole cell protein lysates (25µg/lane) using colon mucosal stripping from NCre 
and WT mice with acute colitis. Blots were probed with (A) anti-COX-2 (B) anti-iNOS (C) anti-
NF-kB and (D) anti-Cyclin-D1.  β-tubulin was used as loading control. 
2.3.6 Notch1 promotes wound healing 
Eight weeks old, both female and male, NCre mice and WT mice induced with acute 
colitis by DSS were allowed to recover for 7 days as described in the methods section. Their 
body weight was monitored throughout the experiment and mice were euthanized on day 12. 
Figure 10A shows that at the end of DSS phase NCre mice had significantly body weight loss 
compared to WT mice. However, during recovery phase, NCre mice were unable to recover 
compared to WT mice. Figure 10B shows colonoscopy images indicating the increased mucosa 
thickening, bleeding, and inflammation among NCre mice (indicated by red arrows) compared to 
WT mice after 7 days of recovery. Figure 10C-i shows the histological images indicating that 
NCre mice presented increased loss of crypt architecture, neutrophil infiltration, and foci of 
ulceration compared to WT mice. Figure 10C-ii is the bar graph representation of the histological 
inflammatory score based on three parameters mentioned in the methods section indicating that 
NCre mice had a significantly higher histological score compared to WT mice after the recovery 
phase. Furthermore, to test the hypothesis that Notch1 signaling indeed promotes colonic wound 
healing, colon carcinoma human cell line HCT116 was used and transiently transfected to 
overexpress NICD as in vitro model. Wound healing assay was performed as described in the 
methods section. Figure 10D-i indicates that NICD overexpression promoted cell migration and 
proliferation to heal the wound compared to control cells. Figure 10D-ii shows the quantification 
of wound closure indicating that HCT116 cells overexpressing NICD initiated wound closure by 
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24 hours (87.3%) compared to control cells (91.5 %). Together these data indicate that Notch1 
signaling mediates wound healing at recovery phase following acute colitis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NCre and WT mice (n=5 each group) were treated with one cycle of 2% DSS for 5 days and 
went under a recovery phase for 7 days. Body weight was monitored every day and mice were 
Figure 10. Notch1 promotes wound healing in the recovery phase following acute colitis. 
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euthanized at day 12. (A) Line graph representation of body weight change in percentage of 
NCre and WT mice during one cycle of DSS and one recovery phase. (B) Colonoscopy images 
from WT mice (top panel) water, acute colitis, and recovery phase, respectively. The bottom 
panel shows the same treatments for NCre mice. Arrows indicate signs of inflammation and 
thickening of mucosa layer. (C) H&E staining of colon cross sections from NCre and WT mice 
completed a recovery phase. (C-i) Magnified view of the squared area is shown in the right side 
of the original picture at X40 indicating the disrupted architecture of crypts and infiltration of 
neutrophils. (C-ii) Bar graph representation of histological score calculated on three parameters: 
infiltration of neutrophils, loss of crypt architecture, and foci of ulceration. (D) Wound healing 
assay of human colon carcinoma HCT116 cells transfected to overexpressed NICD. (D-i) Cell 
proliferation and migration was monitored and images were taken at 0hrs, 24hrs, and 48 hrs. (D-
ii) Quantification of wound closure was performed by calculating the wound area using ImageJ 
program and it is represented as percent initial wound. Data represent the mean ± S.E., *p< 0.05. 
 
2.4 Discussion 
UC is a form of IBD causing inflammation and ulcers in the colon either in 
segments or completely. The main symptom of active disease is usually constant diarrhea 
mixed with blood. UC as its name suggests, affects only the colon and rectum, leaving the 
rest of the GI tract unaffected, hence is very different from CD (another form of IBD). 
Although UC has no known cause, presumed genetic component and susceptibility to western 
diet and lifestyle increases the prevalence of this disease. UC is triggered in a susceptible 
person by environmental factors, although dietary modifications may reduce the discomfort 
of a person with the disease. Recent Studies of migrant populations as well as populations 
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of developing countries have demonstrated a slow but steady increase in the incidence of UC 
[72]. The incidence of UC is higher than CD incidence in the United States [73]. UC is 
characterized by continuous inflammation throughout the colon affecting the mucosal layer of 
the GI tract compromising epithelial cells integrity and increasing the paracellular permeability 
allowing the entrance of foreign antigens and microorganisms to the lamina propria [8, 52]. 
 Notch1 signaling is a highly conserved intercellular signal transduction pathway 
which is induced upon environmental cues. It is associated with colonic inflammation [26] and 
colon cancer [74]. Notch1 is a key player in the differentiation of intestinal stem cells to 
epithelial /enterocyte lineage [75]. Notch1 activation requires three cleavages: two extracellular 
and one intracellular [35]. Translocation of Notch1 intercellular domain (NICD) to the nucleus 
activates downstream targets such as Hes, c-Myc. These downstream targets are directly 
involved with differentiation, inflammation, or carcinogenesis pathways [35].  
 Inflammatory mediators modulate Notch1 signaling and have been documented in acute 
colitis. However, the precise mechanistic role of Notch1 signaling in acute colitis is not well 
understood. Therefore, in the present study, a conditional Notch1 knockout mice (NCre) lacking 
Notch1 expression in colon epithelial cells was generated to identify the role and mechanism of 
Notch1 in acute colitis. 
We observed that the conditional deletion of Notch1 in colonic epithelial cells resulted in 
higher histological score, increased goblet cells population, defective barrier function, 
compromised epithelial cell differentiation and proliferation, and liver inflammation at the basal 
level. Interestingly, we also observed that silencing of Notch1 signaling attenuated inflammation 
in the in vivo DSS-induced acute colitis model as implied by colonoscopy, decreased MPO 
levels, and higher histological score. These data together showed less severity of colonic 
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inflammation among NCre mice compared to WT mice. Although, in acute colitis the 
conditional deletion of Notch1 signaling did not cause goblet cell hyperplasia among NCre mice 
compared to WT mice.  
Recent studies have found the activation of Notch1 during inflammation. Dysregulated 
Notch1 signaling has been associated with inflammatory conditions such as rheumatoid arthritis 
[76], systemic lupus erythematosus  [77], pre-term labor [78], bacterial infection [79]. Although, 
one can also reason that inflammatory cells modulate Notch1 through canonical and non-
canonical signaling pathways [80]. Inflammation can stimulate the Notch1 pathway through an 
extrinsic stimulus like recognition of pathogen infection toll-like receptors (TLRs) activating 
innate immune cells or through an intrinsic stimulus such as immune signaling molecules 
(cytokines) [26]. Our data shows that interestingly the conditional deletion of Notch1 
significantly decreased mRNA levels of pro-inflammatory cytokine, IL-6, increased mRNA 
levels of the pro-inflammatory cytokines: IL-1β, IFN-γ, and TNF-α, while it decreased anti-
inflammatory cytokines: IFN-γ and IL-17 compared to Notch+/+ mice with acute colitis. 
Increased levels of pro-inflammatory cytokine IL-6 among Notch+/+ mice with acute colitis 
might be due to the possible non-canonical activation of Notch1 signaling in the cytoplasm to 
intrinsically upregulate IL-6 signaling mediating inflammation in acute colitis. compared to WT 
mice in acute colitis. 
Additionally, there was no difference in the expression of COX-2, an inflammatory 
enzyme mediator, in both NCre and WT mice. Several of the transcription factors regulate COX-
2 are known to be activated by inflammatory cytokines [81] , which explains a low but constant 
expression in both NCre and WT  mice induced with acute colitis. There was also negligible 
expression of i-NOS, which is known to produce nitric oxide that dysregulates inflammatory 
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processes and causes tissue injury [82]. However, we observed a significant decrease in NF-kB 
protein levels as well as its downstream target cyclin D1 among NCre mice compared to WT in 
acute colitis. NF-kB is an inflammatory pathway [83] which regulates the expression of Cyclin 
D1. Cyclin D1 is a cell cycle progression marker and regulates cell cycle progression and cell 
proliferation [71]. Therefore, this study elucidates that Notch1 signaling mediates acute colitis by 
activating NF-kB signaling pathway. Activation of NF-kB promotes the proliferation of inflamed 
epithelial cells via its downstream target Cyclin D1 as well as IL-6 secretion (Figure 11). 
The epithelial lining of the GI tract continually renews throughout life [84]. This layer 
has the capacity of regenerating whenever there is a damage [85].  During UC, the mature 
epithelial cell migration (restitution process) and regeneration process (proliferation process) gets 
disturbed by the unmanageable progression of inflammation on the mucosal layer. The 
restitution process involving local epithelial cells redistribute around the wound to reseal and 
restore the continuity of this layer but most importantly to preserve homeostasis of the tissue and 
it is mediated by cytokines [57] [58], cell adhesion molecules [59], trefoil factors[56], etc. Cell 
proliferation is required after restitution to replenish the decreased pool of progenitor cells that 
will later differentiate into mature epithelial cells. This lineage decision and maturation of 
epithelial cells is mediated by Notch1 signaling in the GI tract  [28, 86]. Although, Notch1 
signaling seems to mediate inflammation in DSS-induced acute colitis, we sought to further 
investigate its role in the colonic epithelia restitution and regeneration system, in a UC 
completed recovery phase model. 
Interestingly, we observed an opposite role played by Notch1 signaling during recovery 
after acute colitis phase. Notch1 signaling mediated wound healing during recovery phase as 
indicated by gain of body weight, and lower historical score among WT mice compared to NCre 
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mice. Additionally, our in vitro data suggested that the overexpression of NICD in HCT116 cells 
facilitated in the restoration of the scratched-wounded area by the first 24 hrs. Therefore, these 
data together imply that Notch1 plays a contrasting role in recovery phase following acute colitis 
by enhancing wound healing in the colon. 
Our study highlights that Notch1 is critical in the maintenance of epithelial cell integrity, 
goblet cell homeostasis, efficient barrier function, epithelial cell differentiation and proliferation 
under normal conditions. We also observed the contrasting role of Notch1 in acute colitis versus 
a completed recovery phase. Notch1 signaling worsens acute colitis but mediates wound healing 
during recovery phase of acute inflammation. Overall, the modulation of Notch1 signaling in this 
study confirms the differing role of Notch1 signaling in different settings. 
In acute colitis, inflammation causes epithelial-mucosal injury and disrupts the defensive 
barrier against pathogenic luminal contents. Therefore, the delicate equilibrium between healthy 
epithelial-mucosal restitution versus the removal of inflamed epithelium is lost due to 
inflammatory mediators such as cytokines, chemokines, and growth factors. Consequently, 
epithelial cells fail to exit the inflammatory stage. Loss of healthy epithelium is the major 
challenge in preventing acute colitis to chronic inflammation progression. Therefore, as long-
term cure, therapeutics pertinent to epithelial-mucosal restitution are very critical for UC 
patients. The beneficial role of Notch1 in wound healing could be translated as an efficient 
targeted therapy for UC patients. 
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Figure 11. Notch1 signaling mediates inflammation in acute colitis by activating NF-kB 
signaling pathway. 
Activation of NF-kB signaling pathway promotes the proliferation of inflamed epithelial cells via its 
downstream target Cyclin D1 as well as IL-6 cytokine secretion. Abbreviations used are: NICD- Notch1 
intracellular domain; S-2,3-Site 2,3. 
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3 THE ROLE OF NOTCH1 IN COLITIS ASSOCIATED CANCER 
3.1 Introduction 
Although acute or short term inflammation may be self-healing, repeated flares of acute 
inflammation can cause chronic inflammation and contribute to create a tumorigenic 
microenvironment [9] as seen in colitis associates cancer (CAC). Chronic inflammation leads to 
the secretion of proinflammatory cytokines, such as IL-1β, TNF-α, and IL-6, which promote the 
accumulation of reactive oxygen species (ROS) maintaining a pro-inflammatory environment 
favorable for mutations, activation of proliferation and anti-apoptotic pathways [10]. This causes 
a disruption of the intestinal homeostasis, inhibition of the proper communication between the 
epithelial mucosa and adjacent tissues, an altered immune response, DNA damage, and an 
accumulation of mutations in DNA repair genes involved in DNA damage response [13, 14, 87].  
DNA damage response (DDR) signaling is triggered by DNA double-strand breaks (DSBs) 
and it is initiated by phosphatidylinositol-3-like protein kinase ataxia-telangiectasia mutated 
(ATM). Then, a complex known as MRN (MRE11, RAD50, and NBS1) is formed and localized 
to the DSBs together with ATM. After this recruitment, a lysine acetyltransferase 5 (Tip60) binds 
ATM directly which induces its activity and the acetylation of ATM, an early step of ATM 
activation. The phosphorylation of histone H2AX is critical for signal amplification and 
recruitment of DDR factors at DNA lesions. This signal is further amplified by the engagement of 
downstream checkpoint kinases, CHK1 and CHK2, cell-cycle checkpoint components [88]. 
FOXO3a has also been proposed to bind to ATM upon DNA damage and to be necessary for its 
activation [89]. DDR signaling comprises different pathways and one of them is the mismatch 
repair (MMR) pathway. MMR role is to repair base-base mismatches and insertion/deletions loops 
arising from replication errors. Two key proteins in this system are the MutS and MutL families. 
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MutS is comprised by MSH2 and MSH6 proteins and MutL is comprised by MLH1 and PMS1 
proteins. Complexes (MutS/MutL) interact with each other to orchestrate a recruitment of 
downstream repair proteins, such as proliferating cell nuclear antigen (PCNA) , to execute DNA 
repair [90]. 
Complete remission of CAC would require the elimination of inflammation as well as the 
repair of damaged epithelium. Epithelial repair can be done by organized steps of restitution, 
proliferation, and differentiation of epithelial cells. Recent studies have focused in Notch1 
signaling because of its role in cell proliferation, differentiation, and self-destruction processes. 
Studies have shown that disruption of transcription factors downstream of Notch1 signaling, 
such as Hes1, in mice results in the depletion of intestinal epithelial cells [30, 50, 91]. 
Administration of a pharmacological Notch1 inhibitor results in an increase number of goblet 
cells in mice intestine, providing the evidence that Notch1 regulates the linage decision of 
epithelial cells [92, 93]. However, this regulation in a chronic inflammation environment has yet 
to be studied. 
 
Notch1 signaling function has been found to be context dependent in different cell types 
and tissue context, at different developmental stages, and under normal versus pathological 
conditions. Notch1 can be oncogenic or tumor suppressive, this means that it can promote irregular 
differentiation in some tissues [94] or it can help maintain stem cells homeostasis in others [95]. 
Its oncogenic role was first illustrated in 1991 where Notch1 was suspected to be related to the 
development of T-cell acute lymphocytic leukemia (T-ALL)/lymphoma [96]. Studies have shown 
that activated Notch1 can induce neoplastic transformation in mouse mammary and salivary glands 
and in rat kidney cells in vitro [97-99]. Another study mentions that Notch signaling is required 
for the neoplastic transformation in Ras-transformed human breast cancer cells [98]. Studies in 
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mice have shown that Notch1 signaling in sporadic colon cancer (CRC) is also oncogenic and it is 
required for adenoma formation due to the elevated Wnt signaling that occurs in adenomatous 
polyposis coli/multiple intestinal neoplasia (ApcMin) mice model of colon cancer [28, 44, 100, 
101]. Moreover, activated Notch1, via β-catenin, has the oncogenic role in promoting primary 
melanoma cells progression [102]. 
However, different studies have shown that Notch1 is not exclusively oncogenic, it can 
also act as a tumor suppressor depending on the inflammatory stimulus and context. For example, 
Liu et al have shown that deletion of Notch1 in one allele leads to vascular tumors and massive 
hemorrhage in the liver and it is associated with decreased mice survival suggesting a Notch1 
tumor suppressive function [95]. Another study using Notch1-deficient mice, in epidermis and 
corneal epithelium, developed basal-cell-carcinoma like tumors after being chemical-induced for 
carcinogenesis, again suggesting a tumor suppressor role in the mammalian skin [103]. Notch1 
also functions as a tumor suppressor by inhibiting the tumor growth of mouse prostate cancer cells 
[104] and small cell lung cancer cells [105]. It was previously shown that inhibition of Notch1 by 
the γ-secretase inhibitor DAPT (N- [N-(3,5 difluorophenacetyl)-1-alanyl 1]-S-phenylglycine t-
butyl ester) reduces apoptosis and promotes CAC. As previously mentioned, different groups have 
also shown that Notch1 has a protective role in a variety of malignancies such as as prostate cancer 
[104], cervical cancer [106, 107] and skin cancer [103]. However, the precise mechanism of action 
of Notch1 signaling in CAC remains unclear. Therefore, understanding the mechanistic role of 
Notch1 would assist in the identification of key proteins and signaling pathways that are critical to 
treat CAC development. Additionally, this could also bring a direct treatment to prevent cancer in 
UC patients. 
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3.2 Materials and Methods 
3.2.1 Colitis associated cancer (CAC) induction 
Ten weeks old, both female and male, NCre and WT mice were injected intraperitoneally 
with Azoxymethane (AOM) (7.6 mg/kg) (Sigma-Aldrich), a cancer inducer, on day 0. On day 7, 
both mice groups were exposed to 2% DSS (w/v) (MP Biomedicals, Solon, OH) by oral 
administration through their drinking water for 7 days. On day 14, their water was changed to 
regular drinking water. On day 28, a second cycle of 2% DSS was administered to both groups 
and after a week DSS was changed to regular drinking water and mice were euthanized on day 
56 (Figure 12). Body weight and stool consistency of all mice was monitored during DSS and 
recovery phase. 
 
Figure 12. AOM/DSS- induced colitis associated cancer (CAC) model. 
 
3.2.2 Protein extraction and Western blot (WB) analysis 
Colon mucosal stripping was obtained from NCre and WT mice with and without CAC. 
Antibodies used were anti-NICD (Cell signaling), anti-p53 (Cell Signaling), anti-Cleaved 
caspase 3, (Cell Signaling), anti-p21WAF1/Cip1 (BD Biosciences), anti-γH2AX (Abcam), and anti-
MLH1 (Abcam). Goat anti-mouse secondary antibody (Bio-Rad, Hercules, CA) or goat anti-
rabbit secondary antibody (Abcam) were use. β-tubulin (Sigma-Aldrich) or GAPDH (Abcam) 
were used as loading control. 
Abbreviations used are: D-Day, AOM- Azoxymethane, and DSS-Dextran sodium sulfate. 
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3.2.3 Mouse colonoscopy 
NCre and WT mice with and without CAC were subjected to colonoscopy to assess the 
mucosal layer thickness due to inflammation and dysplastic lesions. This was performed using 
the colonoscope (Xenon Nova 47S, STORZ). 
3.2.4 Hematoxylin and Eosin (H&E) staining and histological score evaluation 
Formalin fixed and paraffin embedded colon Swiss rolls from NCre and WT mice with 
and without CAC were used. Histological scores were evaluated based on inflammation-
infiltration of white blood cells, crypt damage, and foci of ulceration in the entire colon. Images 
were taken using a Keyence BZ-X700 microscope at X20 and X40 magnification. 
3.2.5 Alcian Blue- Periodic Acid Schiff (AB-PAS) staining 
Formalin fixed and paraffin embedded colon Swiss rolls from NCre and WT mice with 
and without CAC were used. Sections were hydrated and incubated with acetic acid for 3 min. 
Next, sections were stained with 3% Alcian blue (Sigma-Aldrich). After washing, sections were 
incubated with 0.5% periodic acid and then with Schiff reagent (Sigma-Aldrich) at room 
temperature. Sections were then hydrated with alcohol, cleared with xylene, and sealed. Images 
were taken using a Keyence BZ-X700 microscope at X20 magnification. 
3.2.6 Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) 
staining 
Paraffin sections of colons were deparaffinized and apoptotic cells were identified by 
immunofluorescent terminal deoxynucleotidyl transferase–mediated deoxyuridine triphosphate 
nick-end labeling (TUNEL) staining using In Situ Cell Death Detection Kit (Millipore-Sigma), 
Fluorescein according to the manufacturer’s instructions. Quantification of apoptosis was 
performed by counting the number of apoptotic cells in a crypt and was shown as percentage. 
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3.2.7 In vivo-permeability assay 
Ten weeks-old age, both female and male, NCre and WT mice treated with or without 
CAC were gavaged with permeability tracer (60 mg/100g body weight of FITC-labeled dextran) 
(Sigma-Aldrich). Serum was collected retro-orbitally 4 h after gavage and fluorescence intensity 
of each sample was measured at λex=492 nm; λem= 525 nm by using Synergy 2; BioTek. FITC-
dextran concentrations were determined from standard curves generated by serial dilutions of 
FITC-dextran and permeability was calculated by linear regression of sample fluorescence. 
3.2.8 Myeloperoxidase (MPO) assay 
NCre and WT with and without CAC colon tissue samples were homogenized in cold 
potassium phosphate buffer (50 mmol/l K2HPO4 and 50 mmol/l KH2PO4, pH 6.0) containing 
0.5% hexadecyltrimethylammonium bromide (Sigma-Aldrich). The homogenates were sonicated 
(40% amplitude), freeze-thawed three times and centrifuged (4ᵒC at 14,000 rpm). MPO activity 
in the samples was determined and compared to MPO standard (Sigma-Aldrich) after measuring 
the absorbance at 450nm. 
3.2.9 RNA extraction and QPCR 
Total RNA was extracted from colonic tissues using the RNeasy mini Kit (Qiagen) 
according to the manufacturer’s instructions. Then, complementary DNA was generated from the 
earlier-described total RNA isolated using the Maxima first-strand complementary DNA 
synthesis kit (ThermoFisher Scientific). mRNA expression was quantified by quantitative real-
time reverse-transcription polymerase chain reaction using Maxima SYBR green quantitative 
polymerase chain reaction Master Mix (ThermoFisher Scientific). The following sense and 
antisense primers (Table 1) were used: TNF-a, S1008A, S100A9, and 16SrRNA. Real-time PCR 
data is presented using the DDCT method and using 36B4 gene levels as the internal standard 
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3.2.10 Statistical analysis 
All data was expressed as means ± SEM and were compared by Student’s t-test [69]. P 
values <0.05 was considered statistically significant. 
 
3.3 Results 
3.3.1 Conditional deletion of Notch1 in colonic epithelium increases CAC 
susceptibility 
Ten weeks old, both male and female, NCre and WT mice were induced with CAC as 
described in the methods section. Body weight was monitored throughout the experiment and 
mice were euthanized at day 56. Figure 13A shows the body weight change in percentage 
indicating that NCre mice had a significant decrease in body weight at the end of week 5 and 
week 6 compared to WT mice in CAC. Figure 13B shows a bar graph representation of colon 
length indicating that there was a significant decrease in colon length among the NCre mice 
compared to WT mice in CAC. Figure 13C shows colonoscopy images indicating that NCre 
mice presented flat polyps, thickened mucosa, and inflammation compared to WT mice in CAC. 
Figure 13D shows the quantification of the polyps indicating that there was indeed a significant 
number of polyps on NCre mice (7.2 ± 1.75) compared to WT mice (4.0 ± 0.82) in CAC. Figure 
13E shows the histological images of colon Swiss rolls indicating increased infiltration of 
inflammatory cells, an extensive loss of crypt architecture, increased foci of ulceration, and 
dysplasia among NCre mice compared to WT mice in CAC. Figure 13F is the bar graph 
representation of the histological score based on the criteria as mentioned in the methods section. 
The bar graph indicated that NCre mice presented significantly higher histological score (9.4 ± 
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1.38) compared to WT mice (7.29 ± 1.11) in CAC. Together these data indicate that deletion of 
Notch1 signaling in the colon exacerbates CAC condition. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Conditional deletion of Notch1 in colonic epithelium results in increased 
susceptibility to CAC. 
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NCre and WT mice (n=7 each group) were treated with one AOM intraperitoneal injection and 2 
cycles of 2% DSS to induce CAC. Body weight were monitored throughout the experiment and 
mice were euthanized at day 56. (A) Line graph representation of body weight change of NCre 
and WT (B) Bar graph representation of colon length among NCre mice and WT mice in CAC. 
(C) Colonoscopy images from WT mice (top panel) and NCre mice (bottom panel). Arrows 
indicate polyps, the thickening of mucosa, and inflammation. (D) Bar graph representation of 
number of polyps among NCre mice and WT mice in CAC. (E) H&E staining of colon Swiss 
rolls from NCre mice and WT mice in CAC. Left panel shows images at X10 and right panel at 
X20. (F) Bar graph presentation of the histological score calculated on three parameters- 
infiltration of neutrophils, loss of crypt architecture and foci of ulceration. Each bar represents 
mean ± S.E., *p< 0.05, **p<0.01, ***p< 0.001. 
3.3.2 Notch1 signaling modulates cytokine levels, maintains epithelial cell integrity 
and barrier function, and maintains the microbiome population 
Chronic inflammation favors the secretion of pro-inflammatory cytokines and damaged-
associated molecular pattern molecules (DAMPs) nurturing the tumor microenvironment that can 
progress to carcinogenesis and metastasis [108, 109]. The mRNA expression level of pro-
inflammatory cytokine, TNF-α, and damage-associated molecular pattern (DAMP) molecules, 
such as S100A8 and S100A9, were measured by performing QPCR. Figure 14A shows the 
significantly increased levels of TNF-α among NCre mice (2.36 ± 1.13-fold) compared to WT 
mice (0.64 ± 0.09-fold) in CAC. Figure 14B interestingly shows no significant difference in 
mRNA levels of S100A8 in both NCre mice (4.11 ± 2.78-fold) compared to WT mice (1.34 ± 
0.47-fold) in CAC. However, Figure 14C shows significantly decreased levels of S100A9 among 
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NCre mice (1.22 ± 0.60-fold) compared to WT mice (2.59 ± 0.65) in CAC. In the setting of 
chronic inflammation, the epithelial barrier function is compromised which worsens CAC 
conditions, resulting in the downregulation of the microbial population. Epithelial barrier 
function was assessed by gavaging mice with 4kD FITC-dextran. Figure 14D shows significantly 
increased number of FITC units among NCre mice (39.5 ± 8.6) compared to WT mice (23.9 ± 
3.12) in CAC. Figure 14E shows decreased levels of 16SrRNA (universal bacteria primer) among 
NCre mice (1.73 ± 0.8-fold) compared to WT mice (3.21 ± 0.24-fold) in CAC. Together these 
data indicate that conditional deletion of Notch1 promotes the secretion of pro-inflammatory 
cytokine, TNF-α, and impairs epithelial cell integrity and microbiota population in CAC. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
45 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NCre and WT mice (n=7 each group) were treated with one AOM intraperitoneal injection and 2 
cycles of 2% DSS to induce CAC. Bar graph representation of qPCR analyses representing 
Figure 14. Conditional deletion of Notch1 increases cytokine levels and disrupts 
colonic epithelia cell barrier function in CAC. 
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mRNA levels of cytokine and DAMP molecules, in colonic mucosal stripping from NCre and 
WT mice in CAC, respectively. (A) TNF-α (B) S100A8 and (C) S100A9. (E) In vivo 
permeability was performed by gavaging NCre and WT mice with 4kD FITC-dextran in PBS 
(60mg/100g body weight). Then, serum via retro-orbitally was collected after 4 hrs, and the 
fluorescence within the blood was measured at λex=492 nm; λem= 525. (D)  Bar graph 
representation of qPCR analysis representing mRNA levels of 16SrRNA. Each bar represents 
mean ± S.E., *p< 0.05, **p< 0.01, NS= non-significant. 
3.3.3 Notch1 signaling activates tumor suppressor p53 and downstream target 
p21WAF1/Cip1 increasing apoptosis and decreasing DDR and MMR proteins in 
CAC 
The secretion of pro-inflammatory cytokines, under chronic inflammation, promotes the 
accumulation of reactive oxygen species (ROS), promoting a pro-inflammatory environment 
favorable for oncogene activation and tumor suppressor gene mutations. NICD, the cleaved 
cytoplasmic domain of Notch1, can translocate to the nucleus and activate tumor suppressor 
transcription factors, such as p53 which also happens to be the first gene mutation to appear in 
CAC. Therefore, to identify the mechanistic pathway by which Notch1 signaling acts as a tumor 
suppressor in CAC, protein lysates from the colon mucosal stripping were used for western blot 
analysis as described in the methods section. Figure 15A-i confirms the lack of NICD protein 
expression (lanes 4-6) among NCre mice compared to WT mice (lanes 1-3) in CAC. Figure 15A-
ii indicates the absence of p53 protein among NCre mice (lanes 4-6) compared to WT mice 
(lanes 1-3) in CAC. ROS accumulation, due to chronic inflammation, can produce DNA damage, 
accelerate cancer cell growth, and alter anti-apoptotic pathways increasing mutations in DNA 
response (DDR) and mismatch repair (MMR) genes, which are two important cellular events for 
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the maintenance of healthy epithelium [10, 13-15, 110]. To assess apoptosis in CAC, TUNEL 
staining was performed in the colonic epithelium. Figure 15B shows the overlay image 
indicating that there was a significant decrease in apoptosis, as indicated by white arrows, among 
NCre mice compared to WT mice in CAC. Further, to confirm the activation of apoptosis 
associated proteins, Caspase-3 and p21WAF1/Cip1, in CAC, WB analysis was performed. Figure 
15C shows decreased protein level of cleaved caspase-3 among NCre mice (lanes-3-5) compared 
to WT mice (lanes 1-2) in CAC. Figure 15D-ii also shows the decreased protein level of 
p21WAF1/Cip1 among NCre mice (lanes 4-5) compared to NCre mice (lanes 1-3) in CAC. To assess 
the effects of conditional deletion of Notch1 on DDR and MMR proteins in CAC, WB analyses 
of γ-H2AX and MLH1 were performed. Figure 15D-i and 14D-iii show higher protein levels of 
y-H2AX and MLH1 among NCre mice (lanes 4-5) compared to WT mice (lanes 1-3) in CAC. 
Together these data indicate that conditional deletion of Notch1 in colonic epithelium is 
associated with lower levels of p53, p21, and apoptosis. Therefore, absence of Notch1 signaling 
leads to increase DNA damage and impaired MMR pathway. 
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Figure 15. Notch1 exhibits a tumor suppressor role by increasing apoptosis and DDR and 
MMR proteins in CAC. 
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NCre and WT mice (n=7 each group) were treated with one AOM intraperitoneal injection and 2 
cycles of 2% DSS to induce CAC. Western blots of protein from colon mucosal stripping from 
NCre and WT mice induced with CAC were used and probed with (A-i) anti-NICD (A-ii) 
antip53 and (C) anti-Cleaved caspase-3. (B) The overlay images of green-yellow nuclei 
apoptotic cells as indicated by white arrows. Magnification at X20. (D) WB of protein from 
colon mucosal stripping from NCre and WT mice induced with CAC were used and probed with 
(D-i) anti-γ-H2AX (D-ii) anti-p21WAF1/Cip1 and (D-iii) anti-MLH1. β-actin or GAPDH was used 
as a loading control and each lane shows (25ug/lane) from an individual mouse. 
3.4 Discussion 
Chronic inflammation increases the risk for developing cancer. It is known that patients 
with chronically active UC have a 15-40% risk of developing CAC due to the long duration of the 
inflammation in the colon [4]. CAC progresses from dysplastic tissue to adenoma and it is different 
from colorectal cancer (CRC) progression. CRC progression starts from adenoma to carcinoma 
stage. Chronic inflammation environment is a complex network involving different cell types, 
inflammatory cytokines, signaling molecules, extracellular matrices, etc. that work together to start 
carcinogenesis. Indeed, chronic inflammation favors to the secretion of proinflammatory 
cytokines, such as IL-1β, TNF-α, and IL-6, which promote the accumulation of reactive oxygen 
species (ROS) and maintains a pro-inflammatory environment favorable for oncogene activation 
and tumor suppressor gene mutations, activation of abnormal proliferation and differentiated anti-
apoptotic pathways [10]. This disrupts the colonic epithelial homeostasis and ruptures the normal 
communication between the epithelial mucosa and adjacent tissues, alters immune responses, leads 
to DNA damage, and mutations in DNA response (DDR) genes worsening CAC condition [13-
15].  
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The mammalian receptor, Notch1, which is highly expressed at the basal crypt of the 
human colon [38], is known for stem cell renewal, progenitor cell-fate determination, terminal 
differentiation of proliferating cells, and tissue homeostasis in the healthy colon [20, 21, 38, 40]. 
Notch1 activation leads to the transcription of downstream target genes, such as hairy enhancer of 
split 1 (Hes1), which is critical in the lineage decision for progenitor cells to differentiate in colonic 
epithelial cells [39, 111]. Studies have defined Notch1 role to be context dependent, it can be 
oncogenic [96, 97] or tumor suppressive [112], therefore, it can promote irregular differentiation 
in some tissues [94] or it can help maintain stem cells homeostasis in others [95].  
 
Its oncogenic role was first illustrated in 1991 where Notch1 was suspected to be related 
to the development of T-cell acute lymphocytic leukemia (T-ALL)/lymphoma [96]. Studies have 
shown that activated Notch1 can induce neoplastic transformation in mouse mammary and salivary 
glands and in rat kidney cells in vitro [97-99]. Another study mentions that Notch signaling is 
required for the neoplastic transformation in Ras-transformed human breast cancer cells [98]. 
Studies in mice have shown that Notch1 signaling in CRC is also oncogenic and it is required for 
adenoma formation due to the elevated Wnt signaling that occurs in adenomatous polyposis 
coli/multiple intestinal neoplasia (ApcMin) mice model of colon cancer [28, 44, 100, 101]. 
However, different studies have shown that Notch1 is not exclusively oncogenic, in fact it can also 
act as a tumor suppressor. Liu et al. have shown that chronic inhibition of Notch1 leads to vascular 
tumors in the liver and it is associated with decreased survival suggesting the tumor suppressive 
role of Notch1 [95]. Another study using Notch1-deficient mice, in epidermis and corneal 
epithelium, developed basal-cell-carcinoma like tumors after being chemical-induced for 
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carcinogenesis, again suggesting a tumor suppressor role in the mammalian skin [103]. Notch1 
also functions as a tumor suppressor by inhibiting the growth of mouse prostate cancer cell [104].  
It has been previously shown that inhibition of Notch1 by the γ-secretase inhibitor DAPT 
(N- [N-(3,5 difluorophenacetyl)-1-alanyl 1]-S-phenylglycine t-butyl ester) reduces apoptosis 
during CAC [113]. Although, in recent years, different studies have reported the protective role of 
Notch1 in various malignancies however, the underlying precise mechanism Notch1 signaling in 
CAC remains unclear. Understanding the role of Notch1 in CAC is critical and will assist in 
unraveling novel efficient therapeutics to prevent carcinogenesis in the chronically inflamed colon 
tissue. We hypothesized that Notch1 acts as a tumor suppressor in CAC by activating tumor 
suppressor p53 [114] and p21 (downstream target of p53) by regulating cell cycle progression for 
DNA repair of damaged cells. In this study, we observed that conditional deletion of Notch1 
signaling exacerbated CAC conditions as indicated by the shortening of colon length, increased 
dysplastic lesions, mucosa thickening, increased number of polyps, loss of crypt architecture, 
increased infiltration of white blood cells, and higher histological score. These all represent 
severity of CAC under chronic inflammatory colonic conditions. Moreover, our data shows that 
the conditional deletion of Notch1 promoted the secretion of pro-inflammatory cytokine, TNF-α, 
which is one of the cytokines critical in nurturing tumor environment in CAC.  
Damage-associated molecular pattern molecules (DAMP) contribute significantly in 
mediating inflammation, modulating tumor growth and metastasis [109]. Interestingly, we 
observed that mRNA level of the DAMP molecule, S100A8, was no different between both 
groups, however, S100A9 mRNA level was increased in Notch+/+ mice compared to NCre mice 
in CAC. Further, the reason why S100A9 might be high in Notch+/+ mice could be due to the 
recent discovery from LI et al. mentioning that S100A9 has several putative p53 binding sites 
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meaning that its overexpression can induce apoptosis in a p53 dependent manner [115]. This was 
also supported by the p53 WB analysis in our study indicating increased p53 protein expression 
among WT mice compared to NCre mice in CAC. Our data supports the fact that, conditional 
deletion of Notch1 in CAC, disrupts the colonic epithelial cell integrity compromising epithelial 
cell barrier as indicated by the increase number of FITC units compared to Notch+/+ mice. This 
impaired barrier function and epithelial integrity results in the decreased of microbiota 
population among NCre mice compared to WT mice. Therefore, our data elucidates that 
conditional deletion of Notch1 results in microbiota depletion causing an imbalance epithelial 
homeostasis and favoring chronic inflammation in CAC. 
Disruption of the colonic epithelial homeostasis leads to the increase in DNA damage and 
for damaged epithelial cells to evade apoptosis. Critical cellular events, such as DRR and MMR, 
activate to the rescue to repair and replenish healthy epithelial cells in the damaged tissue. Our 
data shows that the conditional deletion of Notch1 is associated with lower levels of tumor 
suppressor- p53 and apoptosis associated protein- p21WAF1/Cip1 while it increases DDR sensors-
γH2AX and MMR protein-MLH1 indicating that Notch1 signaling absence increases DNA 
damage, decreases apoptosis, and compromises DDR and MMR pathways. In conclusion, we 
demonstrate that Nocth1 plays a tumor suppressor role in CAC, by activating p53 and p21 and 
by promoting DDR and MMR activity to maintain healthy colonic epithelial cells over 
inflamed/damaged ones (Figure 16). 
Tissue specific deletion of Notch1 in colonic epithelium worsened CAC conditions. Both, 
epithelial injury and lack of epithelial healing, favor chronic inflammation progression to 
dysplasia. Epithelial injury is primarily caused due to the ROS generation during chronic 
inflammation. Therefore, as an efficient and long-term preventive strategy for CAC, therapeutic 
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interventions are required to limit the chronic inflammation at the initial stages. This window is 
very critical to avoid the extensive and irreversible damage caused by the inflammatory 
environment leading to cancer in CAC. Overall, activation of Notch1 in the early stages of 
chronic inflammation could be an efficient preventive therapeutic strategy for CAC progression. 
 
 
 
 
 
 
Figure 16. Notch1 plays a tumor suppressor role in CAC. 
Notch1 signaling plays a tumor suppressor role in CAC by activating p53 and downstream 
target p21 and by promoting DDR and MMR activity to maintain healthy colonic epithelial 
cells over inflamed/damaged ones. Abbreviations used are: NICD-Notch intracellular 
domain, S2-S3-Site2 and Site3; TJ-Tight junction; ROS- Reactive oxygen species; MMR- 
Mismatch Repair pathway 
54 
3.5 Conclusion 
IBD is a chronic condition that involve dysregulated immune response and inflammation 
of the gastrointestinal (GI) tract [1, 6]. UC is a form of IBD that affects the rectum and 
inflammation also spreads throughout the colon affecting the inner layer of the colon as well as 
the mucosa. Patients with active UC have a 15-40% risk of developing colitis associated cancer 
(CAC) due to the longterm inflammation in the colon [4]. CAC is a subtype of colorectal cancer 
which develops from dysplasia to carcinoma axis among chronically active UC patients [10-12]. 
Notch1 is highly expressed at the basal crypt of the human colon [38] and it plays a role 
in stem cell renewal, progenitor cell-fate determination, terminal differentiation of proliferating 
cells, and tissue homeostasis in the colon [20, 21, 38, 40]. Notch1 activation can be multifaceted, 
depending on the severity of the disease, Notch1 can be protective or deleterious. Previous 
studies have found that Notch1 has a beneficial role in corneal and skin healing while it is 
deleterious in breast cancer [116-118]. Interestingly, Notch1 has been found to be upregulated in 
early stages of cervical cancer; whereas, it is downregulated in late stages of cervical cancer 
[119-121]. Notch1 signaling can activate cancer associated transcription factors  such as, c-Myc, 
ARF and p53 [122]. It can also activate Hes transcription factor implicated in the maintenance of 
progenitor and stem cells; thus, promoting epithelial cell differentiation in the colon [39]. 
Therefore, Notch1 function is context dependent, it can be oncogenic or tumor suppressive.  It 
was previously shown that pharmacological inhibition of Notch1 decreases apoptosis and 
promotes CAC progression during the disease [113]. In recent years, different groups have also 
shown that Notch1 has a protective role in a variety of malignancies such as prostate cancer 
[104], cervical cancer [106, 107] and skin cancer [103]. However, the precise mechanism of 
Notch1 signaling in acute colitis and CAC remains unclear. 
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In this study, we sought to explore the role of Notch1 through different stages of colitis, 
starting from acute inflammation to CAC. Understanding the role of Notch1 will assist in the 
improvement for treatments to prevent carcinogenesis in chronically inflamed colon tissues. We 
hypothesized that Notch1 activation mediates inflammation in acute colitis; however, it plays a 
protective role during CAC. This hypothesis was addressed by two aims which can potentially 1) 
target inflammatory pathways which mediate acute inflammation via Notch1 activation 2) bring 
a more specific treatment to prevent the development of cancer in IBD patients. 
To study the role of Notch1 in acute colitis and CAC, we generated a conditional knockout 
mouse (NCre) using the Cre/Lox system. NCre mice do not express Notch1 in epithelial cells. 
The first section of this dissertation goes over the characterization of NCre mice. We showed that 
the conditional deletion of Notch1 leads to higher numbers of goblet cells and compromises 
epithelial crypt architecture and colonic barrier function. We also showed that the conditional 
deletion of Notch1 compromises epithelial cell differentiation and proliferation in the colon. In 
addition, biochemical blood analytes showed significantly higher among NCre mice indicating 
that there was inflammation in their livers compared to the control mice. 
Next, we explored if Notch1 activation mediates inflammation in acute colitis. By using a 
DSS- induced colitis model, we showed that Notch1 mediates inflammation in acute colitis as it 
upregulates pro-inflammatory (IL-6) and downregulates anti-inflammatory (IFN-γ) cytokines. 
Notch1 activation in DSS-induced model also activated NF-kB-Cyclin D1 inflammatory 
pathway which promotes proliferation favoring inflammation in acute colitis. Notch1 is known 
for its role in colonic stem renewal, progenitor-cell fate determination, and tissue homeostasis; 
therefore, we also wanted to explore the role of Notch1 in wound healing in the recovery phase 
following acute colitis. By using a DSS-induced colitis recovery model and HCT116 cells 
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transfected to overexpress NICD, we showed that Notch1 indeed promotes wound healing in the 
recovery phase following acute colitis. Therefore, Notch1 signaling plays an opposite role as it 
protected the mice, during the recovery phase, from mediating inflammation. 
 In CAC, chronic inflammation leads to the secretion of proinflammatory cytokines, which 
promotes the accumulation of ROS and maintains a pro-inflammatory environment favorable for 
oncogenes and mutations in tumor suppressor genes. Chronic inflammation dysregulates the 
balance between proliferation and apoptotic pathways. Altogether, contribute to the disruption of 
intestinal homeostasis [10, 13, 14, 87]. To study the role of Notch1 in CAC, mice were injected 
with azoxymethane, a carcinogen, and treated with two cycles of DSS. In the second section of 
this dissertation, we showed that the conditional deletion of Notch1 in the colonic epithelium 
increases CAC susceptibility by disrupting epithelial cell integrity, barrier, and microbiota 
population. We also showed that the conditional deletion of Notch1 promoted the secretion of 
pro-inflammatory cytokine, TNF-α, as well as increased DNA damage and decrease in apoptosis. 
In addition, Notch1 conditional deletion in colon impaired DDR sensors and MMR pathway. 
Therefore, these data suggest that Notch1 acts as a tumor suppressor in chronic colitis.  
In conclusion, these results imply that Notch1 activation is context dependent. Depending 
on the severity of the disease, in this case acute colitis, we showed that Notch1 is deleterious 
during acute inflammation. However, Notch1 activation can be protective during chronic 
colitis/CAC. These results could further be translated to a potential therapeutic solution for IBD 
patients. Notch1 target inhibitors should be avoided during acute inflammation and the induction 
of Notch1 signaling can be protective in CAC.  
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